Compare ELAN & MOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | MOH |
|---|---|---|
| Founded | 1954 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 8.9B |
| IPO Year | 2018 | 2003 |
| Metric | ELAN | MOH |
|---|---|---|
| Price | $25.18 | $133.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 13 |
| Target Price | $24.44 | ★ $185.00 |
| AVG Volume (30 Days) | ★ 4.7M | 2.2M |
| Earning Date | 02-24-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.07 | ★ 8.92 |
| Revenue | $4,591,000,000.00 | ★ $43,563,000,000.00 |
| Revenue This Year | $7.25 | $7.91 |
| Revenue Next Year | $5.80 | $8.13 |
| P/E Ratio | $350.10 | ★ $14.21 |
| Revenue Growth | 3.08 | ★ 11.23 |
| 52 Week Low | $8.02 | $121.06 |
| 52 Week High | $26.08 | $359.97 |
| Indicator | ELAN | MOH |
|---|---|---|
| Relative Strength Index (RSI) | 58.50 | 29.59 |
| Support Level | $24.76 | $121.06 |
| Resistance Level | $26.08 | $185.40 |
| Average True Range (ATR) | 0.71 | 7.41 |
| MACD | 0.01 | -6.88 |
| Stochastic Oscillator | 62.36 | 15.17 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Molina provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in just four states—California, New York, Texas, and Washington—account for over half of its enrollees.